Tina's Wish

What Tina's Wish does

Tina's Wish (legally The Honorable Tina Brozman Foundation, Inc.) is a 501(c)(3) nonprofit charitable organization founded in 2008 and headquartered at 240 W. 40th St., Suite 202, New York, NY. The organization is dedicated exclusively to funding scientific research for the early detection and prevention of ovarian cancer, the deadliest gynecologic cancer for which no effective screening test currently exists. It was established in memory of Tina Brozman, who passed away from the disease. The foundation does not develop proprietary technology; instead, it channels donations into external research teams working on liquid biopsy platforms, microRNA-based blood tests, extracellular vesicle diagnostics, epigenetic detection methods (cfMethyl-SeqV2), microfluidic assays (PapDREAMing), and carbon nanotube nanosensors, with reported accuracy above 96% in early studies of microRNA-based detection.

Tina's Wish operates two primary grant programs: Team Science Grants of $400,000 over two years for collaborative multi-investigator projects, and Rising Star Grants of $150,000 over two years for early-career researchers. In the 2026-27 cycle alone, the foundation is funding at least nine Team Science projects spanning Dana-Farber, Johns Hopkins, University of Pennsylvania, Brigham and Women's Hospital, MIT, UPMC, MD Anderson, UCLA, and University of Kansas, among others. The cumulative funded footprint extends across 15+ premier US research institutions. In February 2026, Tina's Wish joined a $12 million coalition led by The Mark Foundation for Cancer Research alongside AACR, Lustgarten Foundation, and Break Through Cancer to expand into early detection research for pancreatic and esophageal cancers.

The foundation generates revenue through a diversified mix of individual donations, corporate matching, planned giving/bequests, securities transfers, tribute cards, and a portfolio of fundraising events. Signature events include the Annual Gala (which raised $3.4M in 2025 and $3.0M in 2024, attracting 850+ supporters), the Runway for Research fashion event ($400K-$555K annually), regional gatherings in Boston, Chicago, D.C. Metro, Southern California, and Virginia ($100K-$150K each), NextGen young professional events, TCS New York City Marathon team fundraising, and corporate lunch & learn programs with partners including KKR, Wells Fargo, Bank of America/Merrill Lynch, Standard Chartered, White & Case, and Weil Gotshal & Manges. The organization is governed by a Board of Directors and a Scientific Advisory Board, with Beverly Wolfer serving as Executive Director.

Name

Tina's Wish

Legal name

The Honorable Tina Brozman Foundation, Inc.

Website

https://tinaswish.org

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

Tina's Wish is a 501(c)(3) nonprofit founded in 2008 that funds external scientific research for the early detection and prevention of ovarian cancer. It awards Team Science and Rising Star grants to researchers at 15+ US institutions and sustains operations through galas, regional events, and corporate partnerships.

Ownership category

akta.pro rank

Product category

Cancer Research Nonprofit Foundation

NAICS

Grantmaking Foundations (813211), Voluntary Health Organizations (813212)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

akta.pro secondary industries

Research & Science Grantmaking Foundations (BPAGAKAI), Public Charities & Grantmaking Intermediaries (BPAGAKAE)

Keywords

• Ovarian cancer research
• Cancer early detection
• Research grant funding
• Nonprofit health foundation
• Cancer awareness education

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Individual Donations: Direct donations from individuals supporting ovarian cancer early detection research. Donors can give online, by check, or through securities transfers.
2. Corporate Matching: Many organizations match their employees' charitable giving, doubling the impact of individual donations.
3. Annual Benefit Dinner/Gala: Major annual fundraising event. The 2025 Annual Gala raised $3.4 million, the 2024 Annual Gala raised $3 million.
4. Regional Gatherings: Local fundraising events in cities including Chicago, Boston, Virginia, D.C. Metro, and Los Angeles. Events typically raise $100k-$150k each.
5. Leadership Council Events: High-level donor events including the annual Runway for Research fashion event, raising $300k-$555k annually.
6. Athletic Events: Partnership with TCS New York City Marathon and other athletic fundraising events.
7. Securities and Stock Donations: Accepts transfers of individual stock or mutual funds as charitable donations.
8. Bequests and Planned Giving: Designating The Honorable Tina Brozman Foundation as a beneficiary of estate, life insurance policy, retirement account, or charitable trusts.
9. Tribute/Holiday Cards: In lieu of traditional cards, donors can honor loved ones with donations in support of early detection research.
10. Coalition Funding Contribution: Participating in a $12 million coalition investment across six collaborative research projects focused on pancreatic, ovarian, and esophageal cancers.

Distribution channels2 records

Marketing channels11 records

Core offering

Tina's Wish is a 501(c)(3) nonprofit foundation that raises charitable contributions and awards competitive research grants focused on the early detection of ovarian cancer. Its portfolio includes large Team Science collaborative grants awarded to multi-institution research teams and smaller Rising Star Grants awarded to promising early-career investigators. The foundation also operates education and awareness programs and hosts fundraising events in support of its research mission.

Product overview

Tina's Wish (The Honorable Tina Brozman Foundation) is a 501(c)(3) charitable organization dedicated to early detection and prevention of ovarian cancer. The organization operates as a research funding nonprofit rather than a traditional technology product company. Its core offering consists of grant programs funding scientific research at major research institutions, including Team Science Grants and Rising Star Grants supporting collaborative research projects focused on developing early detection methods for ovarian cancer. The organization also conducts education and awareness programs and hosts fundraising events to support its mission.

Differentiator

Problem solved

Functional benefit

Products and services

• Team Science Grant Program The Team Science Grant program is a multi-institution, collaborative research grant of approximately $2.5 million awarded competitively to research teams at major academic medical centers for projects focused on the early detection of ovarian cancer. It is intended for principal investigators and their collaborators who can demonstrate cross-institutional scientific collaboration.
• Rising Star Grant Program The Rising Star Grant program provides approximately $100,000 in research funding to early-career investigators conducting innovative work in ovarian cancer early detection, supporting pipeline development for the next generation of researchers.
• Ovarian Cancer Education and Awareness Programs Public education and awareness initiatives that disseminate information about ovarian cancer symptoms, risk factors, and the importance of early detection to at-risk women and the broader public.
• Fundraising Events and Galas In-person fundraising events, including galas and community gatherings, designed to engage donors, raise funds, and increase awareness for the foundation's ovarian cancer early detection mission.

Quantifiable outcome

• MicroRNA-based blood test can detect early-stage ovarian cancer with over 96% accuracy
• +4 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

30 partnerships are on record, tiered core and minor.

• The Mark Foundation for Cancer ResearchcoreStrategic or Co-development Partner · 4 February 2026Coalition leader that launched a $12 million initiative across six collaborative research projects focused on early detection of pancreatic, ovarian, and esophageal cancers. Tina's Wish is a participating member of this coalition.
• American Association for Cancer Research (AACR)coreStrategic or Co-development Partner · 4 February 2026Leading nonprofit cancer research organization participating in the coalition for early detection of deadly cancers.
• Lustgarten FoundationcoreStrategic or Co-development Partner · 4 February 2026Leading nonprofit pancreatic cancer research organization participating in the coalition for early detection of deadly cancers.
• Break Through CancercoreStrategic or Co-development Partner · 4 February 2026Nonprofit cancer research organization participating in the coalition for early detection of deadly cancers.
• Cleveland CliniccoreStrategic or Co-development PartnerResearch institution where Tina's Wish-funded researchers (Dr. Kevin Elias) conduct early detection research including the MiDe Study.
• Dana-Farber Cancer InstitutecoreStrategic or Co-development PartnerMajor research partner home to multiple Tina's Wish-funded researchers including Dr. Dipanjan Chowdhury and Dr. Jarrod Marto working on microRNA and proteomics research.
• Johns Hopkins UniversitycoreStrategic or Co-development PartnerKey research partner with multiple funded researchers including Dr. Ie-Ming Shih, Dr. Thomas Pisanic, Dr. Tza-Huei Wang, Dr. Tian-Li Wang, and Dr. Victor Velculescu working on PapDREAM and liquid biopsy technologies.
• Memorial Sloan Kettering Cancer CentercoreStrategic or Co-development PartnerResearch partner where Dr. Daniel Heller and Dr. Kara Long Roche conduct nanotechnology and liquid biopsy research for adnexal mass triage.
• University of Pennsylvania (Penn Medicine)coreStrategic or Co-development PartnerMajor research partner home to Dr. Ronny Drapkin (Director of Ovarian Cancer Research Center) and multiple collaborative projects on fallopian tube biology and early interception.
• Massachusetts Institute of Technology (MIT)coreStrategic or Co-development PartnerResearch partner where Dr. Angela Belcher and Dr. Kripa Varanasi collaborate on biophysical markers and mesenchymal stromal cell research for early detection.
• University of ChicagocoreStrategic or Co-development PartnerResearch partner where Dr. Chuan He and Dr. Ernst Lengyel work on epigenetic cell-free DNA biomarkers and multimodal plasma-based detection.
• University of Kansas Medical CentercoreStrategic or Co-development PartnerResearch partner where Dr. Andrew Godwin and Dr. Steven Soper conduct extracellular vesicle liquid biopsy research.
• UCLAcoreStrategic or Co-development PartnerResearch partner where Dr. Gottfried Konecny leads medical gynecologic oncology research on cell-free DNA approaches.
• M.D. Anderson Cancer CentercoreStrategic or Co-development PartnerResearch partner where Dr. Sammy Ferri-Borgogno and Dr. Samuel Mok conduct glutamine targeting research for ovarian cancer prevention.
• Columbia UniversitycoreStrategic or Co-development PartnerResearch partner where Dr. Tal Danino engineers probiotic bacteria for early detection and interception of ovarian cancer.
• Brigham and Women's HospitalcoreStrategic or Co-development PartnerResearch partner where Dr. Kevin Elias directs the Gynecologic Oncology Laboratory and collaborates on microRNA research.
• UT Southwestern Medical CentercoreStrategic or Co-development PartnerResearch partner where Dr. Lindsay Cowell, Dr. Salvatore LoCoco, Dr. Elena Lucas, and Dr. Nancy Monson work on T cell responses for early detection.
• University of Pittsburgh Medical Center (UPMC)coreStrategic or Co-development PartnerResearch partner where Dr. Lan Coffman studies stromal biomarkers and mesenchymal stromal cells for early-stage detection.
• Virginia Commonwealth UniversitycoreStrategic or Co-development PartnerPartner institution for Tina's Wish research grants.
• University of MichigancoreStrategic or Co-development PartnerResearch partner where Dr. Deepak Nagrath collaborates on glutamine targeting research.
• KKRminorGTM or Marketing PartnerCorporate partner hosting lunch & learn events on genetic testing and ovarian cancer awareness for employees.
• Weil, Gotshal & MangesminorGTM or Marketing PartnerLaw firm partner that hosted Ovarian Cancer Awareness Month lunch & learn event.
• AlixPartnersminorGTM or Marketing PartnerConsulting firm partner hosting Ovarian Cancer Awareness Month lunch & learn with gynecologic oncologist speaker.
• FTI ConsultingminorGTM or Marketing PartnerConsulting firm partner that hosted lunch & learn for Ovarian Cancer Awareness Month.
• Standard Chartered BankminorGTM or Marketing PartnerBanking partner hosting lunch & learn event featuring Tina's Wish funded physician-scientist.
• Gordon BrothersminorGTM or Marketing PartnerCorporate partner hosting lunch & learn event combining science and personal experience perspectives.
• MIO PartnersminorGTM or Marketing PartnerCorporate partner hosting 'Coffee with a Cause' advocacy gathering.
• Wells FargominorGTM or Marketing PartnerBanking partner that hosted lunch & learn at Boston office with researcher Dr. Kevin Elias.
• Bank of America/Merrill LynchminorGTM or Marketing PartnerFinancial services firm that hosted Ovarian Cancer Awareness Month lunch & learn with Dr. Kara Long Roche.
• White & CaseminorGTM or Marketing PartnerLaw firm partner that hosted lunch & learn with Dr. Kara Long Roche for employee education.

Scale indicators16 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Stand Up To Cancer: Large-scale cancer research fundraising organization funding collaborative 'Dream Teams' across institutions. Comparable as a peer cancer research grantmaker with similar multi-institutional collaborative funding model and high-visibility fundraising events.
• American Cancer Society: Largest U.S. cancer nonprofit, funding broad cancer research, education, and patient support. Comparable as a large incumbent cancer research funder competing for the same donor and corporate partnership dollars.

Direct peers

• Lustgarten Foundation: Leading pancreatic cancer research foundation and Tina's Wish coalition partner. Comparable as a high-performing, disease-specific cancer research grantmaker with a similar gala/regional fundraising model and academic research portfolio.
• National Foundation for Cancer Research: Long-standing nonprofit funding cancer research across multiple cancer types. Comparable as a peer cancer-focused research grantmaking nonprofit with similar donor-driven funding model.
• V Foundation for Cancer Research: Major cancer research grantmaking foundation funding translational research across cancer types. Comparable as a peer cancer research funder with competitive grant programs and large annual fundraising events.
• The Mark Foundation for Cancer Research: Cancer research grantmaker leading the $12M coalition that Tina's Wish participates in. Comparable as a peer cancer research funding organization distributing competitive grants to academic investigators at premier institutions.
• National Ovarian Cancer Coalition: National nonprofit dedicated to ovarian cancer awareness, support, and research. Comparable as a peer ovarian-cancer-focused nonprofit running education programs, regional chapters, and fundraising events similar to Tina's Wish.
• Ovarian Cancer Research Alliance (OCRA): The largest nonprofit focused on ovarian cancer, funding research grants and advocating for patients. Directly comparable as a disease-specific ovarian cancer research grantmaker competing for the same donor pool and researcher network.
• Break Through Cancer: Cancer research foundation funding collaborative, multi-institutional early detection and treatment projects. Directly comparable as a Tina's Wish coalition partner with shared collaborative-grant model targeting high-mortality cancers.

Emerging players

• Bright Pink: Nonprofit focused on breast and ovarian cancer risk reduction and early detection for young women. Comparable as a smaller, emerging peer with overlapping early-detection mission for women's cancers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/TinasWish
• YouTubeyoutube.com/channel/UCChE2AR3nO7Byk9Yit7nDNA
• Facebookfacebook.com/TinasWishFoundation
• LinkedInlinkedin.com/company/the-honorable-tina-brozman-foundation-for-ovarian-cancer-rsearch-tina's-wish-
• Instagraminstagram.com/tinaswish

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tina's Wish